Search
Now showing items 1-6 of 6
Article
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys
| Date Issued:
2020 | Copyright:
restricted access
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Date Issued:
2017 | Copyright:
open access
Article
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
| Date Issued:
2017 | Copyright:
open access
Article
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
| Date Issued:
2019 | Copyright:
open access
Article
Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika
| Date Issued:
2023 | Copyright:
restricted access